Related Experiment Video
Updated: Feb 23, 2026

08:40
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
20.3K
The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production
Aaron M Tocker1, Emily Durocher1, Kimberly D Jacob1
1Department of Biology, Franklin and Marshall College, Lancaster, PA 17604.
Journal of Immunology (Baltimore, Md. : 1950)
|September 3, 2017
Summary
IQGAP1 interacts with NLRC3 to regulate type I interferon production. Disrupting this interaction boosts antiviral responses, suggesting IQGAP1 as a novel regulator of innate immunity signaling.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Type I interferons (IFNs) are crucial for antiviral defense, initiated by cytosolic nucleotide sensing.
- Stimulator of IFN genes (STING) is a key receptor that signals downstream to activate IFN regulatory factors.
- NLRC3 negatively regulates type I IFN production by inhibiting STING signaling.
Purpose of the Study:
- To investigate the role of IQGAP1 in the regulation of type I IFN production.
- To determine if IQGAP1 interacts with NLRC3 and influences the NLRC3-STING interaction.
Main Methods:
- Yeast two-hybrid screening to identify potential interacting partners of NLRC3.
- Co-immunoprecipitation assays to confirm interactions between IQGAP1 and NLRC3.
- Knockdown studies using siRNA in THP1 and HeLa cells to assess the impact on IFN-β production.
- Analysis of STING-NLRC3 interactions in human epithelial cells.
Main Results:
- IQGAP1 was identified as a binding partner of NLRC3.
- IQGAP1 disrupts the interaction between NLRC3 and STING in the cytosol.
- Knockdown of IQGAP1 leads to increased IFN-β production in response to cytosolic nucleic acids, mimicking NLRC3 deficiency.
Conclusions:
- IQGAP1 negatively regulates type I IFN production by interfering with NLRC3-STING complex formation.
- IQGAP1 acts as a novel regulator in the type I IFN pathway, particularly in human monocytic and epithelial cells.
- These findings elucidate a new mechanism controlling innate immune responses to cytosolic nucleic acids.
Related Concept Videos
The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
TGF - β Signaling Pathway
10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Regulation of the Unfolded Protein Response
3.1K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Experimental RNAi
8.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

